The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Open accessAbstract
Coronavirus disease 2019 (COVID-19) has swept the world, unlike any other pandemic in the last 50 years. Our understanding of the disease has evolved rapidly since the outbreak; disease prognosis is influenced mainly by multi-organ involvement. Acute respiratory distress syndrome, heart failure, renal failure, liver damage, shock and multi-organ failure are strongly associated with morbidity and mortality. The COVID-19 disease pathology is plausibly linked to the hyperinflammatory response of the body characterized by pathological cytokine levels. The term ‘cytokine storm syndrome’ is perhaps one of the critical hallmarks of COVID-19 disease severity. In this review, we highlight prominent cytokine families and their potential role in COVID-19, the type I and II interferons, tumour necrosis factor and members of the Interleukin family. We address various changes in cellular components of the immune response corroborating with changes in cytokine levels while discussing cytokine sources and biological functions. Finally, we discuss in brief potential therapies attempting to modulate the cytokine storm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
WHO Declares COVID-19 a Pandemic.
Cucinotta, D., & Vanelli, M. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i1.9397 · Cited by 7,457
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Henter, J., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J., et al. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21039 · Cited by 5,386
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472
COVID-19 and its implications for thrombosis and anticoagulation
Connors, J. M., & Levy, J. H. (2020) · Blood · doi:10.1182/blood.2020006000 · Cited by 2,369
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., Sundaram, M., Ellingson, M. K., Mao, T., Oh, J. E., Israelow, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2588-y · Cited by 2,074
Coronavirus infections and immune responses
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., Pan, P., Wang, W., Hu, D., Liu, X., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25685 · Cited by 1,946
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768 · cited 2×
“Along with IL-6, IFN-γ has been a reliable indicator of COVID-19 patient deterioration and ICU admission [37,38,41].”
BackgroundCOVID-19 infection: the perspectives on immune responses
Shi, Y., Wang, Y., Shao, C., Huang, J., Gan, J., Huang, X., Bucci, E., Piacentini, M., Ippolito, G., & Melino, G. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-0530-3 · Cited by 1,594
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
Li, M.-Y., Li, L., Zhang, Y., & Wang, X.-S. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00662-x · Cited by 1,583
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic
(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0772 · Cited by 1,537
Acute kidney injury in patients hospitalized with COVID-19
Hirsch, J. S., Ng, J. H., Ross, D. W., Sharma, P., Shah, H. H., Barnett, R. L., Hazzan, A. D., Fishbane, S., Jhaveri, K. D., Abate, M., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.05.006 · Cited by 1,523
Fardet, L., Galicier, L., Lambotte, O., Marzac, C., Aumont, C., Chahwan, D., Coppo, P., & Hejblum, G. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38690 · Cited by 1,475
An overview of the immune system
Parkin, J., & Cohen, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04904-7 · Cited by 1,460
Panigada, M., Bottino, N., Tagliabue, P., Grasselli, G., Novembrino, C., Chantarangkul, V., Pesenti, A., Peyvandi, F., & Tripodi, A. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14850 · Cited by 1,315
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., Qi, Y., Sun, R., Tian, Z., Xu, X., & Wei, H. (2020) · National Science Review · doi:10.1093/nsr/nwaa041 · Cited by 1,295
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG, C. K., LAM, C. W. K., WU, A. K. L., IP, W. K., LEE, N. L. S., CHAN, I. H. S., LIT, L. C. W., HUI, D. S. C., CHAN, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,274
Potent and Selective Stimulation of Memory-Phenotype CD8+ T Cells In Vivo by IL-15
Zhang, X., Sun, S., Hwang, I., Tough, D. F., & Sprent, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80564-6 · Cited by 1,245
Menter, T., Haslbauer, J. D., Nienhold, R., Savic, S., Hopfer, H., Deigendesch, N., Frank, S., Turek, D., Willi, N., Pargger, H., et al. (2020) · Histopathology · doi:10.1111/his.14134 · Cited by 1,230
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
Herold, T., Jurinovic, V., Arnreich, C., Lipworth, B. J., Hellmuth, J. C., von Bergwelt-Baildon, M., Klein, M., & Weinberger, T. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.008 · Cited by 1,161
The safety and side effects of monoclonal antibodies
Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A., & George, A. J. T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3003 · Cited by 1,144
Pedersen, S. F., & Ho, Y.-C. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137647 · Cited by 1,137
Clinical and virological data of the first cases of COVID-19 in Europe: a case series
Lescure, F.-X., Bouadma, L., Nguyen, D., Parisey, M., Wicky, P.-H., Behillil, S., Gaymard, A., Bouscambert-Duchamp, M., Donati, F., Le Hingrat, Q., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30200-0 · Cited by 1,092
Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo
Tough, D. F., Borrow, P., & Sprent, J. (1996) · Science · doi:10.1126/science.272.5270.1947 · Cited by 1,077
Astuti, I., & Ysrafil (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.020 · Cited by 1,070
Sutton, C., Brereton, C., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,010
Cavalli, G., De Luca, G., Campochiaro, C., Della-Torre, E., Ripa, M., Canetti, D., Oltolini, C., Castiglioni, B., Tassan Din, C., Boffini, N., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30127-2 · Cited by 970
Zheng, H.-Y., Zhang, M., Yang, C.-X., Zhang, N., Wang, X.-C., Yang, X.-P., Dong, X.-Q., & Zheng, Y.-T. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0401-3 · Cited by 940
Lin, L., Lu, L., Cao, W., & Li, T. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1746199 · Cited by 914
Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis
Coomes, E. A., & Haghbayan, H. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2141 · Cited by 883
T cell responses in patients with COVID-19
Chen, Z., & John Wherry, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0402-6 · Cited by 797
Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)
(2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000819 · Cited by 784
Liu, B., Li, M., Zhou, Z., Guan, X., & Xiang, Y. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102452 · Cited by 763
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Schulte, W., Bernhagen, J., & Bucala, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/165974 · Cited by 745
Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin
Hu, H., Ma, F., Wei, X., & Fang, Y. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa190 · Cited by 687
COVID-19 vaccine development and a potential nanomaterial path forward
Shin, M. D., Shukla, S., Chung, Y. H., Beiss, V., Chan, S. K., Ortega-Rivera, O. A., Wirth, D. M., Chen, A., Sack, M., Pokorski, J. K., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0737-y · Cited by 659
Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
Zeni, F., Freeman, B., & Natanson, C. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00001 · Cited by 648
Anakinra for severe forms of COVID-19: a cohort study
Huet, T., Beaussier, H., Voisin, O., Jouveshomme, S., Dauriat, G., Lazareth, I., Sacco, E., Naccache, J.-M., Bézie, Y., Laplanche, S., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30164-8 · Cited by 643
Hyperferritinemia and inflammation
Kernan, K. F., & Carcillo, J. A. (2017) · International Immunology · doi:10.1093/intimm/dxx031 · Cited by 638
Management of acute kidney injury in patients with COVID-19
Ronco, C., Reis, T., & Husain-Syed, F. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30229-0 · Cited by 634
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology
Batlle, D., Soler, M. J., Sparks, M. A., Hiremath, S., South, A. M., Welling, P. A., Swaminathan, S., & on behalf of the COVID-19 and ACE2 in Cardiovascular, L. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040419 · Cited by 614
Candidate drugs against SARS-CoV-2 and COVID-19
McKee, D. L., Sternberg, A., Stange, U., Laufer, S., & Naujokat, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104859 · Cited by 562
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
Mahallawi, W. H., Khabour, O. F., Zhang, Q., Makhdoum, H. M., & Suliman, B. A. (2018) · Cytokine · doi:10.1016/j.cyto.2018.01.025 · Cited by 558
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Feldmann, M., Maini, R. N., Woody, J. N., Holgate, S. T., Winter, G., Rowland, M., Richards, D., & Hussell, T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30858-8 · Cited by 536
Pleiotropy and specificity: insights from the interleukin 6 family of cytokines
Murakami, M., Kamimura, D., & Hirano, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.027 · Cited by 533
The effects of IL-6 on CD4 T cell responses
Dienz, O., & Rincon, M. (2009) · Clinical Immunology · doi:10.1016/j.clim.2008.08.018 · Cited by 526
Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update
Su, H., Lei, C.-T., & Zhang, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00405 · Cited by 524
Chan, M., Cheung, C., Chui, W., Tsao, S., Nicholls, J., Chan, Y., Chan, R., Long, H., Poon, L., Guan, Y., et al. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-135 · Cited by 510
Cohen, J., & Carlet, J. (1996) · Critical Care Medicine · doi:10.1097/00003246-199609000-00002 · Cited by 501
Choudhury, A., & Mukherjee, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25987 · Cited by 488
Totura, A. L., Whitmore, A., Agnihothram, S., Schäfer, A., Katze, M. G., Heise, M. T., & Baric, R. S. (2015) · mBio · doi:10.1128/mbio.00638-15 · Cited by 455
Plasma cytokine levels predict mortality in patients with acute renal failure
Simmons, E. M., Himmelfarb, J., Sezer, M. T., Chertow, G. M., Mehta, R. L., Paganini, E. P., Soroko, S., Freedman, S., Becker, K., Spratt, D., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00512.x · Cited by 444
NLRP3 Inflammasome—A Key Player in Antiviral Responses
Zhao, C., & Zhao, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00211 · Cited by 432
Engineered T Cell Therapy for Cancer in the Clinic
Zhao, L., & Cao, Y. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02250 · Cited by 410
Involvement of IL-6 in mesangial proliferative glomerulonephritis.
Horii, Y., Muraguchi, A., Iwano, M., Matsuda, T., Hirayama, T., Yamada, H., Fujii, Y., Dohi, K., Ishikawa, H., Ohmoto, Y., et al. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.12.3949 · Cited by 408
IL-6/IL-6R Axis Plays a Critical Role in Acute Kidney Injury
Nechemia-Arbely, Y., Barkan, D., Pizov, G., Shriki, A., Rose-John, S., Galun, E., & Axelrod, J. H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007070744 · Cited by 400
Management of Critically Ill Adults With COVID-19
Poston, J. T., Patel, B. K., & Davis, A. M. (2020) · JAMA · doi:10.1001/jama.2020.4914 · Cited by 367
Cytokine storm in acute pancreatitis.
Makhija, R., & Kingsnorth, A. N. (2002) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340200049 · Cited by 365
Min, C.-K., Cheon, S., Ha, N.-Y., Sohn, K. M., Kim, Y., Aigerim, A., Shin, H. M., Choi, J.-Y., Inn, K.-S., Kim, J.-H., et al. (2016) · Scientific Reports · doi:10.1038/srep25359 · Cited by 364
Schmitz, N., Kurrer, M., Bachmann, M. F., & Kopf, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.6441-6448.2005 · Cited by 363
Outbreak of a new coronavirus: what anaesthetists should know
Peng, P. W. H., Ho, P.-L., & Hota, S. S. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.02.008 · Cited by 363
Berg, R. E., Crossley, E., Murray, S., & Forman, J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031051 · Cited by 347
IL-6: Relevance for immunopathology of SARS-CoV-2
Gubernatorova, E. O., Gorshkova, E. A., Polinova, A. I., & Drutskaya, M. S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.009 · Cited by 343
Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome
Zhang, Y., Li, J., Zhan, Y., Wu, L., Yu, X., Zhang, W., Ye, L., Xu, S., Sun, R., Wang, Y., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4410-4415.2004 · Cited by 338
Michot, J.-M., Albiges, L., Chaput, N., Saada, V., Pommeret, F., Griscelli, F., Balleyguier, C., Besse, B., Marabelle, A., Netzer, F., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.300 · Cited by 330
Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J.-C., Paludan, S. R., Klucher, K., & Staeheli, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000151 · Cited by 325
Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity
Bester, J., & Pretorius, E. (2016) · Scientific Reports · doi:10.1038/srep32188 · Cited by 305
Possible importance of macrophage-derived mediators in acute malaria
Clark, I. A., Virelizier, J. L., Carswell, E. A., & Wood, P. R. (1981) · Infection and Immunity · doi:10.1128/iai.32.3.1058-1066.1981 · Cited by 296
Cytokines and T-cell homeostasis
Boyman, O., Purton, J. F., Surh, C. D., & Sprent, J. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.04.015 · Cited by 279
Clinical review: Blood purification for sepsis
Rimmel�, T., & Kellum, J. A. (2011) · Critical Care · doi:10.1186/cc9411 · Cited by 279
Angiotensin-Converting Enzyme II in the Heart and the Kidney
Danilczyk, U., & Penninger, J. M. (2006) · Circulation Research · doi:10.1161/01.res.0000205761.22353.5f · Cited by 269
Homeostatic proliferation and survival of naïve and memory T cells
Boyman, O., Létourneau, S., Krieg, C., & Sprent, J. (2009) · European Journal of Immunology · doi:10.1002/eji.200939444 · Cited by 250
Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
Ferrara, J. L., Abhyankar, S., & Gilliland, D. G. (1993) · PubMed · Cited by 249
Regulation of innate CD8 + T-cell activation mediated by cytokines
Freeman, B. E., Hammarlund, E., Raué, H.-P., & Slifka, M. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203543109 · Cited by 241
Cruz, L. J., Rosalia, R. A., Kleinovink, J. W., Rueda, F., Löwik, C. W. G. M., & Ossendorp, F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.040 · Cited by 235
Self-citationACE2 gene expression is up-regulated in the human failing heart
Goulter, A. B., Goddard, M. J., Allen, J. C., & Clark, K. L. (2004) · BMC Medicine · doi:10.1186/1741-7015-2-19 · Cited by 231
Dominitzki, S., Fantini, M. C., Neufert, C., Nikolaev, A., Galle, P. R., Scheller, J., Monteleone, G., Rose-John, S., Neurath, M. F., & Becker, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2041 · Cited by 227
Role of interleukin 1 in the activation of T lymphocytes.
Lichtman, A. H., Chin, J., Schmidt, J. A., & Abbas, A. K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9699 · Cited by 225
The role of cytokines in T‐cell memory in health and disease
Raeber, M. E., Zurbuchen, Y., Impellizzieri, D., & Boyman, O. (2018) · Immunological Reviews · doi:10.1111/imr.12644 · Cited by 221
Debaugnies, F., Mahadeb, B., Ferster, A., Meuleman, N., Rozen, L., Demulder, A., & Corazza, F. (2016) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqw076 · Cited by 220
Magro, G. (2020) · Cytokine: X · doi:10.1016/j.cytox.2020.100029 · Cited by 215
Moreno-Eutimio, M. A., López-Macías, C., & Pastelin-Palacios, R. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.04.009 · Cited by 178
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
Salvatori, G., Luberto, L., Maffei, M., Aurisicchio, L., Roscilli, G., Palombo, F., & Marra, E. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02392-y · Cited by 177
Jahrling, P. B., Hensley, L. E., Martinez, M. J., LeDuc, J. W., Rubins, K. H., Relman, D. A., & Huggins, J. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405954101 · Cited by 171
Human infection by avian influenza A H5N1.
Yuen, K., & Wong, S. S. Y. (2005) · PubMed · Cited by 168
Ceschi, A., Noseda, R., Palin, K., & Verhamme, K. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00557 · Cited by 159
Yang, R., Masters, A. R., Fortner, K. A., Champagne, D., Yanguas‐Casás, N., Silberger, D. J., Weaver, C. T., Haynes, L., & Rincón, M. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160417 · Cited by 156
IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
Atal, S., & Fatima, Z. (2020) · Pharmaceutical Medicine · doi:10.1007/s40290-020-00342-z · Cited by 155
Nakae, S. (2003) · International Immunology · doi:10.1093/intimm/dxg054 · Cited by 153
Cytokines and the inception of CD8 T cell responses
Cox, M. A., Harrington, L. E., & Zajac, A. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.01.004 · Cited by 146
Zhang, X., Wu, K., Wang, D., Yue, X., Song, D., Zhu, Y., & Wu, J. (2007) · Virology · doi:10.1016/j.virol.2007.04.009 · Cited by 141 · cited 2×
“Notably, evidence for IL-6 production enhancement in SARS-Cov-1 pathogenesis [60] builds the ground for the hypothesis that the two members of the Coronaviridae family might indeed share common physiopathological mechanisms and points out to new possible strategies for therapeutic interventions [65].”
BackgroundMethodSARS-CoV-2 Infection–Associated Hemophagocytic Lymphohistiocytosis
Prilutskiy, A., Kritselis, M. A., Shevtsov, A., Yambayev, I., Vadlamudi, C., Zhao, Q., Kataria, Y., Sarosiek, S., Lerner, A., Sloan, J. M., et al. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa124 · Cited by 132
Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2
Arenas-Ramirez, N., Zou, C., Popp, S. L., Zingg, D., Brannetti, B., Wirth, E., Calzascia, T., Kovařík, J., Sommer, L., Zenke, G., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag3187 · Cited by 129
COVID-19 coagulopathy: an evolving story
Haematology, T. L. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30151-4 · Cited by 129
Lee, S. M. Y., Cheung, C. Y., Nicholls, J. M., Hui, K. P. Y., Leung, C. Y. H., Uiprasertkul, M., Tipoe, G. L., Lau, Y., Poon, L. L. M., Ip, N. Y., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590499 · Cited by 123
Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum
Ronco, C., Reis, T. D. A., & Rosa, S. D. (2020) · Blood Purification · doi:10.1159/000507039 · Cited by 123
van de Veerdonk, F. L., Teirlinck, A. C., Kleinnijenhuis, J., Kullberg, B. J., van Crevel, R., van der Meer, J. W. M., Joosten, L. A. B., & Netea, M. G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809550 · Cited by 110
Insights into the immuno-pathogenesis of acute respiratory distress syndrome
Wong, J. J., Leong, J. Y., Lee, J. H., Albani, S., & Yeo, J. G. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.28 · Cited by 109
Clinical Utility of Extracorporeal Cytokine Hemoadsorption Therapy: A Literature Review
Bonavia, A. S., Groff, A., Karamchandani, K., & Singbartl, K. (2018) · Blood Purification · doi:10.1159/000492379 · Cited by 106
Blocking IL-1 to prevent respiratory failure in COVID-19
van de Veerdonk, F. L., & Netea, M. G. (2020) · Critical Care · doi:10.1186/s13054-020-03166-0 · Cited by 106
T cells instruct myeloid cells to produce inflammasome-independent IL-1β and cause autoimmunity
Jain, A., Irizarry-Caro, R. A., McDaniel, M. M., Chawla, A. S., Carroll, K. R., Overcast, G. R., Philip, N. H., Oberst, A., Chervonsky, A. V., Katz, J. D., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0559-y · Cited by 103
Interleukin-6 in renal disease and therapy
Jones, S. A., Fraser, D. J., Fielding, C. A., & Jones, G. W. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu233 · Cited by 94
Mazaleuskaya, L., Veltrop, R., Ikpeze, N., Martin-Garcia, J., & Navas-Martin, S. (2012) · Viruses · doi:10.3390/v4050901 · Cited by 89
Extracorporeal membrane oxygenation and cytokine adsorption
Datzmann, T., & Träger, K. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.10.128 · Cited by 88
Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
Angelopoulou, A., Alexandris, N., Konstantinou, E. K., Mesiakaris, K., Zanidis, C., Farsalinos, K. E., & Poulas, K. A. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109858 · Cited by 87
Duret, P., Sebbag, E., Mallick, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217362 · Cited by 82
Interleukin 1 plays a major role in the development of Th2‐mediated immunity
Helmby, H., & Grencis, R. K. (2004) · European Journal of Immunology · doi:10.1002/eji.200425452 · Cited by 73
Ng, J. J., Luo, Y., Phua, K., & Choong, A. M. T. L. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.009 · Cited by 72
Honjo, O., Kubo, T., Sugaya, F., Nishizaka, T., Kato, K., Hirohashi, Y., Takahashi, H., & Torigoe, T. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0582-4 · Cited by 71
Use of anakinra in severe COVID-19: A case report
Filocamo, G., Mangioni, D., Tagliabue, P. F., Aliberti, S., Costantino, G., Minoia, F., & Bandera, A. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.026 · Cited by 69
Suggested importance of monokines in pathophysiology of endotoxin shock and malaria
Clark, I. A. (1982) · Journal of Molecular Medicine · doi:10.1007/bf01716573 · Cited by 59
The immune battlefield: The impact of inflammatory cytokines on CD8+ T-cell immunity
Condotta, S. A., & Richer, M. J. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006618 · Cited by 55
Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19
Chang, D., Zhao, P., Zhang, D., Dong, J., Xu, Z., Yang, G., Li, B., Liu, H., Li, B., Qin, C., et al. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.06.015 · Cited by 51
Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?
Zhang, Y., Zhong, Y., Pan, L., & Dong, J. (2020) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2020.03006 · Cited by 46
Ipilimumab (Yervoy) and the TGN1412 catastrophe
Bakács, T., Mehrishi, J. N., & Moss, R. W. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.005 · Cited by 41
COVID-19 poses a riddle for the immune system
Perlman, S. M. (2020) · Nature · doi:10.1038/d41586-020-02379-1 · Cited by 41
Barberis, M., Helikar, T., & Verbruggen, P. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00879 · Cited by 38
Extracorporeal blood purification for sepsis
Shum, H., Yan, W., & Chan, T. M. (2016) · Hong Kong Medical Journal · doi:10.12809/hkmj164876 · Cited by 36
Taylor-Robinson, A. W., & Phillips, R. S. (1994) · PubMed · Cited by 25
Hyperglycemia, Hypertriglyceridemia, and Acute Pancreatitis in COVID-19 Infection
Gadiparthi, C., Bassi, M., Yegneswaran, B., Ho, S., & Pitchumoni, C. S. (2020) · Pancreas · doi:10.1097/mpa.0000000000001595 · Cited by 24
Ugurov, P., Popevski, D., Gramosli, T., Nezir, D., Vuckova, D., Gjorgon, M., Stoicovski, E., Marinkovic, S., Veljanovska-Kiridjievska, L., Ignevska, K., et al. (2020) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2020-0403 · Cited by 23
Self-citationKim, J., Lee, J. Y., Cho, K., Hong, S., Kim, K. S., Sprent, J., Im, S., Surh, C. D., & Cho, J.-H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01907 · Cited by 11
Rosalia, R. A., Štěpánek, I., Polláková, V., Šímová, J., Bieblová, J., Indrová, M., Moravcová, S., Přibylová, H., Bontkes, H. J., Bubeník, J., et al. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.10.012 · Cited by 8
Self-citationWhy a second look might be worth it: immuno-modulatory therapies in the critically ill patient
Siegler, B. H., Brenner, T., Uhle, F., Weiterer, S., Weigand, M. A., & Hofer, S. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.04.37 · Cited by 7
Cited by
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 543
Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review
Al-Qahtani, A. A., Alhamlan, F. S., & Al-Qahtani, A. A. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9010013 · Cited by 291
Metadata
- Authors
- Fara, A., Mitrev, Z., Rosalia, R. A., & Assas, B. M.
- Venue
- Open Biology
- Publisher
- The Royal Society
- Published
- 2020-09
- Volume
- 10
- Issue
- 9
- Pages
- 200160-200160
- ISSN
- 2046-2441 (ISSN-L)
- OpenAlex
- W3087308906
- Cited by
- 369
- References
- 138
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.